Mind Medicine (MindMed) Inc. (DFTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.41
Day's range
$18.49

Definium Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 11.23 M $528.39 M   32.46% 10.33%
AVORO CAPITAL ADVISORS LLC 08/14/2026 7.19 M $338.17 M   43.78% 6.61%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 6.85 M $322.00 M   15.79% 6.29%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 08/24/2026 6.04 M $128.35 M   100.00% 5.55%
JUPITER TOPCO LLC 08/14/2026 5.62 M $264.00 M   100.00% 5.16%
CAPITAL WORLD INVESTORS 08/12/2026 5.37 M $252.50 M   100.00% 4.93%
FMR LLC 08/13/2026 4.75 M $223.58 M   162.65% 4.37%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 4.65 M $218.83 M   6,545.67% 4.28%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.64 M $171.48 M   46.06% 3.35%
STATE STREET CORP 08/07/2026 3.07 M $144.20 M   24.01% 2.82%
CAPITAL INTERNATIONAL INVESTORS 08/12/2026 2.96 M $139.40 M   100.00% 2.72%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 2.95 M $138.77 M   20.90% 2.71%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 2.95 M $138.76 M   126.08% 2.71%
DEEP TRACK CAPITAL, LP 08/14/2026 2.75 M $129.36 M   -8.33% 2.53%
COMMODORE CAPITAL LP 08/14/2026 2.00 M $94.08 M   0.00% 1.84%
ALLIANCEBERNSTEIN L.P. 08/14/2026 1.80 M $34.08 M   1,866.44% 1.66%
GOLDMAN SACHS GROUP INC 08/14/2026 1.80 M $84.71 M   7.49% 1.66%
CITADEL ADVISORS LLC 08/14/2026 1.69 M $79.43 M   26.63% 1.55%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.65 M $77.54 M   88.90% 1.52%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 1.50 M $70.56 M   100.00% 1.38%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.49 M $69.92 M   35.50% 1.37%
SIREN, L.L.C. 08/13/2026 1.42 M $66.77 M   54.38% 1.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.39 M $65.22 M   65.05% 1.27%
MARSHALL WACE, LLP 08/13/2026 1.30 M $61.10 M   8.17% 1.19%
NORTHERN TRUST CORP 08/13/2026 1.17 M $55.00 M   46.34% 1.07%
AMERIPRISE FINANCIAL INC 08/14/2026 1.15 M $54.02 M   18.80% 1.06%
NUVEEN, LLC 08/11/2026 1.11 M $51.99 M   58.33% 1.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.08 M $50.97 M   33.99% 1.00%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.08 M $50.97 M   100.00% 1.00%
WOODLINE PARTNERS LP 08/14/2026 1.00 M $47.21 M   33.32% 0.92%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 1.00 M $47.04 M   -13.04% 0.92%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 998.50 K $46.97 M   66.83% 0.92%
TWO SIGMA INVESTMENTS, LP 08/14/2026 921.82 K $43.36 M   -23.28% 0.85%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 897.66 K $42.23 M   -29.55% 0.83%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 827.69 K $38.93 M   43.71% 0.76%
HOLOCENE ADVISORS, LP 08/14/2026 796.57 K $37.47 M   -27.05% 0.73%
AWM INVESTMENT COMPANY, INC. 08/14/2026 784.80 K $36.92 M   -27.12% 0.72%
BANK OF NEW YORK MELLON CORP 08/06/2026 777.27 K $36.56 M   3.23% 0.71%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 777.25 K $36.56 M   100.00% 0.71%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 710.00 K $33.40 M   3.47% 0.65%
NEUBERGER BERMAN GROUP LLC 08/13/2026 687.54 K $32.34 M   415.52% 0.63%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 682.90 K $32.12 M   60.28% 0.63%
CANDRIAM S.C.A. 08/13/2026 614.43 K $28.87 M   -52.50% 0.56%
ARROWMARK COLORADO HOLDINGS LLC 08/13/2026 564.07 K $26.53 M   -64.63% 0.52%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 562.67 K $26.47 M   -45.79% 0.52%
BLACKSTONE INC. 08/14/2026 561.61 K $26.42 M   10.41% 0.52%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 08/14/2026 550.00 K $25.87 M   37.50% 0.51%
BAMCO INC /NY/ 08/14/2026 520.11 K $24.47 M   100.00% 0.48%
UBS GROUP AG 08/13/2026 499.47 K $23.49 M   1.11% 0.46%
FRANKLIN RESOURCES INC 08/13/2026 486.22 K $22.87 M   100.00% 0.45%

Definium Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 395 institutional investors and hedge funds held shares of Definium Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 11.23 M

Avoro Capital Advisors LLC: 7.19 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 6.85 M

Jupiter Topco LLC: 5.62 M

Capital World Investors: 5.37 M

FMR LLC: 4.75 M

106.41% of Definium Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 119.32 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.